Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Designer Molecules – Engineering a Better Approach to HIV Treatment

20.05.2003


Ravi Kane Receives Grant From the National Institutes of Health



Ravi Kane, assistant professor of chemical engineering at Rensselaer Polytechnic Institute, is designing brand-new molecules that may one day fend off an HIV infection. Bolstering the body’s molecular defenses is a novel method that may lead to highly effective treatments for HIV, the virus that can lead to AIDS.

Kane has received a two-year, $150,000 grant from the National Institute of Allergy and Infectious Disease (NIAID), a division of the National Institutes of Health, to pursue research into this promising HIV treatment.


The Trouble With Today’s Treatments

Today’s FDA-approved HIV treatments take aim at the virus itself. Drugs used in the standard “cocktail” regimens, including reverse transcriptase and protease inhibitors, are intended to disable HIV at two stages in its replication process. Such treatments are undoubtedly lifesaving for many people; however, they deliver varying success due to the ongoing emergence of resistant HIV strains. These drugs are also expensive and lead to a host of side-effects, including lipodystrophy (abnormal fat accumulation or loss in certain parts of the body) and dangerously high cholesterol and triglyceride levels.

A New Approach: Defensive Maneuvers

Kane’s research team at Rensselaer, and Albany Medical Center collaborators Kathy Stellrecht and Dennis Metzger, are trying a different approach. The Rensselaer team is designing molecules that block the particular receptors (located on human cells) that act as the docking sites where the majority of HIV strains make their first attempt at infiltration. These receptors are present all over the cell surface, requiring a molecule with a “multi-armed” (or multivalent) structure to do the best job of preventing a virus from docking.

“Multivalency allows us to block more than one receptor with each molecule,” says Kane. “This approach has the potential to be very effective – in fact, orders of magnitude more effective than any existing treatment.”

There are multiple benefits to treating HIV by blocking its entrance to human cells. In contrast to the constantly mutating virus cells, the human receptors are stable and do not change over time, making development of resistance to a blocking drug unlikely. In addition, the new entry inhibitors may be extremely effective without any dangerous side-effects. People with a genetic defect (a natural blockage) in this receptor show immunity to HIV infection, but are otherwise normal. The researchers admit that this preliminary research is very exciting; however, further study and testing will be needed to develop a viable treatment.

“We hope the next two years of work will form the basis of a more detailed grant in the future,” says Kane.

About Rensselaer
Rensselaer Polytechnic Institute, founded in 1824, is the nation’s oldest technological university. The school offers degrees in engineering, the sciences, information technology, architecture, management, and the humanities and social sciences. Institute programs serve undergraduates, graduate students, and working professionals around the world. Rensselaer faculty members are known for pre-eminence in research conducted in a wide range of research centers that are characterized by strong industry partnerships. The Institute is especially well known for its success in the transfer of technology from the laboratory to the marketplace so that new discoveries and inventions benefit human life, protect the environment, and strengthen economic development.

Joely Johnson | Rensselaer News
Further information:
http://www.rpi.edu/web/News/press_releases/2003/kane.htm

More articles from Health and Medicine:

nachricht Investigators may unlock mystery of how staph cells dodge the body's immune system
22.09.2017 | Cedars-Sinai Medical Center

nachricht Monitoring the heart's mitochondria to predict cardiac arrest?
21.09.2017 | Boston Children's Hospital

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: The pyrenoid is a carbon-fixing liquid droplet

Plants and algae use the enzyme Rubisco to fix carbon dioxide, removing it from the atmosphere and converting it into biomass. Algae have figured out a way to increase the efficiency of carbon fixation. They gather most of their Rubisco into a ball-shaped microcompartment called the pyrenoid, which they flood with a high local concentration of carbon dioxide. A team of scientists at Princeton University, the Carnegie Institution for Science, Stanford University and the Max Plank Institute of Biochemistry have unravelled the mysteries of how the pyrenoid is assembled. These insights can help to engineer crops that remove more carbon dioxide from the atmosphere while producing more food.

A warming planet

Im Focus: Highly precise wiring in the Cerebral Cortex

Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.

The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Rainbow colors reveal cell history: Uncovering β-cell heterogeneity

22.09.2017 | Life Sciences

Penn first in world to treat patient with new radiation technology

22.09.2017 | Medical Engineering

Calculating quietness

22.09.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>